Global Stocks Plunge Amid AI Fears and Inflation Jitters: Investors on Edge

The U.S. government is considering allowing Nvidia to sell its H200 chips to China, according to sources. This potential decision comes amid ongoing scrutiny of semiconductor sales to China, particularly in light of national security concerns. The H200 chips are significant for AI applications, and their sale could have implications for U.S.-China relations in the tech sector.

Nvidia CEO Jensen Huang expressed concerns about the company's position amid discussions of an AI bubble, stating that the market did not recognize the company's strong quarterly performance. Huang's comments were revealed in a leaked meeting, highlighting the challenges Nvidia faces despite its recent successes.

Investors are expressing concerns that the artificial intelligence (AI) sector may be experiencing a bubble, particularly affecting stocks associated with OpenAI, SoftBank, and Oracle. Despite strong earnings from Nvidia and the successful launch of Alphabet's Gemini 3 Pro AI model, stocks related to OpenAI are declining. This trend indicates a selective market reaction within the tech industry, raising questions about the sustainability of AI investments.

The Score is a weekly review highlighting significant stock movements and the news influencing them. This week, notable stocks include Nvidia, Constellation, Eli Lilly, and Gap, with Nvidia's performance particularly impacting market sentiment.

Wall Street's risk machine showed signs of fragility this week, despite a rebound on Friday that spared it from a complete breakdown. The current market cycle has become increasingly vulnerable, reflecting broader concerns about the stability of financial markets amid ongoing volatility.

Nvidia reported strong earnings, projecting sales of approximately $65 billion for the January quarter, surpassing analysts' expectations. Despite this positive outlook, shares fell as concerns about a potential AI bubble persisted among investors. The company's performance remains a focal point in discussions about the sustainability of AI investments.

Following a brief rally in stocks driven by Nvidia's strong earnings, investor concerns about a potential A.I. bubble have resurfaced, leading to significant market fluctuations. The unease surrounding A.I. spending continues to impact investor sentiment negatively.

Lilly has become the first healthcare company to reach a market capitalization of one trillion dollars, marking a significant milestone in the industry. This achievement has garnered a positive reaction from Wall Street, reflecting investor confidence in Lilly's growth prospects and market strategies.